Ribosomal protein L29 pseudogene 3 (RPL29P3)

RPL29P3 is a processed pseudogene annotated in the human genome and officially recognized by HUGO Gene Nomenclature Committee (HGNC:17334)[7]. Pseudogenes, such as RPL29P3, are DNA sequences similar to known genes but typically lack the ability to encode functional proteins due to mutations or truncation. RPL29P3 bears sequence similarity to ribosomal protein L29 (RPL29), which encodes a protein that is a structural component of the 60S large ribosomal subunit and is involved in protein synthesis[1][5]. However, unlike RPL29, RPL29P3 itself does not code for an active protein or serve any direct enzymatic, signaling, or transport function in cells. Therapeutic Target Status RPL29P3 is not considered a therapeutic target, druggable receptor, enzyme, transporter, transcription factor, or biomarker. It cannot be used for targeting by drugs, nor does it have established biological functions or disease associations on its own. Listings as a "target" are likely due to confusion with the functional RPL29 gene[7]. Correctness There is something wrong with this target for drug discovery or therapeutic applications: RPL29P3 is a non-functional pseudogene, not a functional molecule or clinical target. Structured or functional data about protein, drugs, pathways, mechanisms, or disease roles is not relevant to this pseudogene[7]. Summary RPL29P3 (ribosomal protein L29 pseudogene 3) is a human processed pseudogene and not a valid molecular or therapeutic target. When investigating ribosomal functions or drug interactions, the correct entity is ribosomal protein L29 (RPL29), not RPL29P3[1][5][7].

Other names

RPL29P3ribosomal protein L29 pseudogene 3